In the News / Meet With Us / Press Releases


In The News


Meet With Us

CiceroDx to exhibit at American Society of Reproductive Medicine (ASRM) – San Antonio, TX -
(October 28th – November 1, 2017)


Come visit us at ASRM: Booth # 638

Press Releases

CiceroDx announces launch of ReceptivaDx for Unexplained Infertility & Detection of Endometriosis

June 6, 2017 - ‘Breakthrough’ Test for Unexplained Infertility Now Available

June 9, 2017 - - The Breakthrough Option for Treating Unexplained Infertility
Subscribe to our newsletter and stay up to date with ReceptivaDx.
The ReceptivaDxTM Test was developed by CiceroDx in conjunction with Pathology Consultants, Inc. of Greenville, SC. Pathology Consultants, Inc. is a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). As with other laboratory-developed tests, this testing service has not been cleared or approved by the US FDA or any other federal regulatory agencies. Data have not been submitted to or evaluated by Federal regulatory agencies and the test is not for sale as an In Vitro Diagnostic (IVD) in the US or the EU.
© 2017 Receptivadx. All Rights Reserved